| Glen Forrest Huff, MD | |
|
2380 N 400 E, Ste C, North Logan, UT 84341-1749 | |
| (435) 753-7337 | |
| Not Available |
| Full Name | Glen Forrest Huff |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 2380 N 400 E, North Logan, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578520904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 3714601205 (Utah) | Secondary |
| 208M00000X | Hospitalist | 371460-1205 (Utah) | Primary |
| Entity Name | University Of Utah Pediatric Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371 |
News Archive
Researchers from the Barbara Ann Karmanos Cancer Institute in Detroit, MI presented strong evidence today that an antibiotic typically prescribed for Alzheimer's patients could be effective in eventually treating certain types of cancers.
Recent studies employing adult stem cells obtained from bone marrow and fat have been used in patients suffering from osteoarthritis of the knee. Results have indicated not only symptomatic improvement but also suggest that cartilage healing and regeneration may be taking place.
As Secretary of State Hillary Rodham Rodham Clinton travels to Papua New Guinea Wednesday, the Associated Press examines how she will continue to press for "'women empowerment,' a signature issue of her nearly one-year tenure as top U.S. diplomat.'"
In a disappointing new report jointly commissioned by the World Health Organisation (WHO), the UN's AIDS programme and UNICEF it was revealed that only one third of people worldwide who need life-saving HIV drugs are actually getting treated. Universal access to these medicines has been the theme of effort but it was seen that that targets would not be met. The report urges the poorer countries must "substantially ramp up" the funds for HIV/AIDS.
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
› Verified 4 days ago
| Entity Name | University Of Utah Pediatric Acuity Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619325131 PECOS PAC ID: 6406148345 Enrollment ID: O20160713000869 |
News Archive
Researchers from the Barbara Ann Karmanos Cancer Institute in Detroit, MI presented strong evidence today that an antibiotic typically prescribed for Alzheimer's patients could be effective in eventually treating certain types of cancers.
Recent studies employing adult stem cells obtained from bone marrow and fat have been used in patients suffering from osteoarthritis of the knee. Results have indicated not only symptomatic improvement but also suggest that cartilage healing and regeneration may be taking place.
As Secretary of State Hillary Rodham Rodham Clinton travels to Papua New Guinea Wednesday, the Associated Press examines how she will continue to press for "'women empowerment,' a signature issue of her nearly one-year tenure as top U.S. diplomat.'"
In a disappointing new report jointly commissioned by the World Health Organisation (WHO), the UN's AIDS programme and UNICEF it was revealed that only one third of people worldwide who need life-saving HIV drugs are actually getting treated. Universal access to these medicines has been the theme of effort but it was seen that that targets would not be met. The report urges the poorer countries must "substantially ramp up" the funds for HIV/AIDS.
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glen Forrest Huff, MD 2380 N 400 E, Ste C, North Logan, UT 84341-1749 Ph: (435) 753-7337 | Glen Forrest Huff, MD 2380 N 400 E, Ste C, North Logan, UT 84341-1749 Ph: (435) 753-7337 |
News Archive
Researchers from the Barbara Ann Karmanos Cancer Institute in Detroit, MI presented strong evidence today that an antibiotic typically prescribed for Alzheimer's patients could be effective in eventually treating certain types of cancers.
Recent studies employing adult stem cells obtained from bone marrow and fat have been used in patients suffering from osteoarthritis of the knee. Results have indicated not only symptomatic improvement but also suggest that cartilage healing and regeneration may be taking place.
As Secretary of State Hillary Rodham Rodham Clinton travels to Papua New Guinea Wednesday, the Associated Press examines how she will continue to press for "'women empowerment,' a signature issue of her nearly one-year tenure as top U.S. diplomat.'"
In a disappointing new report jointly commissioned by the World Health Organisation (WHO), the UN's AIDS programme and UNICEF it was revealed that only one third of people worldwide who need life-saving HIV drugs are actually getting treated. Universal access to these medicines has been the theme of effort but it was seen that that targets would not be met. The report urges the poorer countries must "substantially ramp up" the funds for HIV/AIDS.
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
› Verified 4 days ago